Company
ROYALTY PHARMA
Funding the next wave of biopharma innovation
Also known as Royalty Pharma Plc
- Status
- IPOas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Founded
- 1996
- Customers
- academic institutions, research hospitals and not-for-profits to small- and mid-cap biotechnology companies and global pharmaceutical companies
- Legal name
- Royalty Pharma Plc
Claim, correct or request removal
Record updated 17 September 2026
About
We are the world’s largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences.
About the company
- Status notes
- Nasdaq: RPRX
Loading relationship preview